Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment

QR Code

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment

In 2010, the International Conference on the Reduction of Drug Related Harm shared its 21st birthday with one of its most constant companions: hepatitis C. The co-occurrence of these significant anniversaries provides an opportunity to reflect critically on the formative role played by hepatitis C,...

Full description

Bibliographic Details
Main Authors:	Fraser, S., Moore, David
Format:	Journal Article
Published:	Routledge 2011
Subjects:	harm reduction medicalisation hepatitis C
Online Access:	http://hdl.handle.net/20.500.11937/7464

Similar Items

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

The definition of harm reduction
by: Lenton, Simon, et al.
Published: (1998)

Clarifying "harm reduction"? Commentary
by: Lenton, Simon, et al.
Published: (1996)

Harm reduction and self-determination. Commentary on Landau C. The prospects of a harm reduction approach among indigenous people in Canada
by: Gray, Dennis
Published: (1996)

Doing the possible: harm reduction, injecting drug use and blood borne viral infections in Australia
by: Loxley, Wendy
Published: (2000)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages
by: Winter, R., et al.
Published: (2013)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

A new agenda for harm minimisation?
by: Stockwell, Tim
Published: (1999)

Harm reduction in Australia: Has it worked? A review
by: Hawks, D., et al.
Published: (1995)

Reducing the harm from adolescent alcohol consumption: Results from an adapted version of SHAHRP in Northern Ireland
by: McKay, M., et al.
Published: (2012)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships
by: Fraser, Suzanne
Published: (2013)

Moderate drinking before the unit: medicine and life assurance in Britain and the US c.1860–1930
by: Kneale, James, et al.
Published: (2015)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

Sharpening the focus of alcohol policy from aggregate consumption to harm and risk reduction.
by: Stockwell, Tim, et al.
Published: (1997)

Assembling the dominant accounts of youth drug use in Australian harm reduction drug education
by: Farrugia, Adrian
Published: (2014)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Cannabis and harm reduction
by: Lenton, Simon
Published: (2000)

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

An evaluation of the opt-out approach to Hepatitis C Virus infection testing in prisons
by: Jack, Kathryn
Published: (2020)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

Participatory Research With an Online Drug Forum: A Survey of User Characteristics, Information Sharing, and Harm Reduction Views
by: Chiauzzi, E., et al.
Published: (2013)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

Cops, drugs and the community: establishing consultative harm reduction structures in two Western Australian locations
by: Midford, Richard, et al.
Published: (2002)

Development of surface plasmon resonance based assay for simultaneous detection of Hepatitis C and B viral infections
by: Akhavanrezaei, Morvarid
Published: (2015)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver
by: Gani, R., et al.
Published: (2014)

How social context impacts on women's fears of childbirth: A Western Australian example
by: Fisher, C., et al.
Published: (2006)

The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy
by: Viramontes Hörner, Daniela, et al.
Published: (2017)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?
by: Wartnaby, Sophie R.
Published: (2023)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
by: Desombere, Isabelle, et al.
Published: (2017)

Detection of Hepatitis B Core Antigen using a Fusion Bacteriophage
by: Hasmoni, Siti Salwa
Published: (2005)